Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-12-18A Randomized, Double-blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 3 Doses of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-12-17A Long-term, Open-label Study Evaluating the Safety and Tolerability of [Vortioxetine] Lu AA21004 in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-12-17An Open-Label Extension Study to Assess the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-12-17Double-blind, Randomised, Placebo-controlled Study Comparing the Efficacy and Safety of Two Fixed Dosages of a Novel Antidepressant Compound to That of Placebo in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-12-13A Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of Lu AA21004 in Subjects With Major Depressive Disorder
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-12-13A Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study Comparing the Efficacy and Safety of Lu AA21004 Versus Placebo in Acute Treatment of Adults With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-11-28Phase 4 Study of Escitalopram Treatment and Biomarkers in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-11-25A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-11-25A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Aripiprazole as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder.
-
CLINICAL_TRIALS study record update · 2013-11-19A Means to Enhanced Cardiovascular Outcomes: Reduction of Exaggerated Platelet Activity Through Treatment of Depression.
-
CLINICAL_TRIALS study record update · 2013-11-19A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
-
CLINICAL_TRIALS study record update · 2013-11-13Emory Conte Center for the Neuroscience of Mental Disorders: Psychobiology of Childhood Trauma
-
CLINICAL_TRIALS study record update · 2013-11-11Does Fluoxetine Reverse the Effects of Early Life Stress on the CNS Corticotropin-Releasing Factor System and Improve Psychological and Neuroendocrine Function?: A Therapy Outcome Study in Women With Childhood Abuse Experiences
-
CLINICAL_TRIALS study record update · 2013-11-08A Multicenter, Long-Term, Open-label, Study to Assess the Safety and Tolerability of Aripiprazole as an Adjunctive Therapy in the Treatment of Outpatients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-11-06A Double-Blind,Venlafaxine-Controlled Study of Efficacy and Safety of Sustained-Release Desvenlafaxine Hydrochloride in the Treatment of Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-11-05An Open-label, Long-Term Extension Study to Assess the Safety and Efficacy of Lu AA21004 in Patients With Major Depressive Disorder (Extension to Lu AA21004/CCT-003 Study)
-
CLINICAL_TRIALS study record update · 2013-10-29A Double-blind, Placebo-Controlled, Fixed-Dose Study of Levomilnacipran SR in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-10-25A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-10-25A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-10-25A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-10-10Attention Training for Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-10-08A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-09-26Serum Brain-Derived Neurotrophic Factor (BDNF) and QEEG as Biological Markers of Response to (Es)Citalopram Treatment in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-09-20A Randomized, Parallel-Group, Sham-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of the Neuronetics Model 2100 CRS Repetitive Transcranial Magnetic Stimulation (rTMS) System in Patients With Major Depression
-
CLINICAL_TRIALS study record update · 2013-09-17Feasibility and Effectiveness of Telepsychiatry for Collaborative Management of Chinese Americans With Psychiatric Disorders in a Nursing Home